CY2496B1 - Antifungal composition. - Google Patents

Antifungal composition.

Info

Publication number
CY2496B1
CY2496B1 CY0400091A CY0400091A CY2496B1 CY 2496 B1 CY2496 B1 CY 2496B1 CY 0400091 A CY0400091 A CY 0400091A CY 0400091 A CY0400091 A CY 0400091A CY 2496 B1 CY2496 B1 CY 2496B1
Authority
CY
Cyprus
Prior art keywords
pct
date nov
azole
sec
antifungal composition
Prior art date
Application number
CY0400091A
Other languages
English (en)
Inventor
Josef Gottfried Meingassner
Neil Stewart Ryder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY2496B1 publication Critical patent/CY2496B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
CY0400091A 1995-05-12 2004-12-27 Antifungal composition. CY2496B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination

Publications (1)

Publication Number Publication Date
CY2496B1 true CY2496B1 (en) 2005-09-02

Family

ID=10774361

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400091A CY2496B1 (en) 1995-05-12 2004-12-27 Antifungal composition.

Country Status (26)

Country Link
US (1) US5985906A (no)
EP (1) EP0824350B1 (no)
JP (1) JPH11504931A (no)
KR (1) KR100443535B1 (no)
CN (1) CN1100539C (no)
AT (1) ATE246504T1 (no)
AU (1) AU712914B2 (no)
CA (1) CA2219651C (no)
CY (1) CY2496B1 (no)
CZ (1) CZ291144B6 (no)
DE (1) DE69629367T2 (no)
DK (1) DK0824350T3 (no)
ES (1) ES2205042T3 (no)
FI (1) FI120079B (no)
GB (1) GB9509631D0 (no)
HK (1) HK1016064A1 (no)
HU (1) HU224920B1 (no)
IL (2) IL118219A0 (no)
MX (1) MX9708699A (no)
NO (1) NO317030B1 (no)
PL (1) PL322749A1 (no)
PT (1) PT824350E (no)
SK (1) SK150797A3 (no)
TW (1) TW464492B (no)
WO (1) WO1996035423A1 (no)
ZA (1) ZA963754B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
ATE264863T1 (de) * 1999-08-24 2004-05-15 Ariad Gene Therapeutics Inc 28-epirapaloge
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
ES2348303T3 (es) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
ZA200708530B (en) 2005-04-07 2009-04-29 Toyama Chemical Co Ltd Pharmaceutical composition and method using antifungal agent in combination
CN101522195B (zh) 2006-10-06 2012-01-18 富山化学工业株式会社 含有苯基脒衍生物的药物组合物和该药物组合物与抗真菌剂的联合使用方法
EP2121572A2 (en) * 2006-12-08 2009-11-25 Auspex Pharmaceuticals Inc. Preparation and utility of substituted allylamines
CA2711765A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
CN105283553B (zh) 2013-06-11 2021-06-25 克隆技术实验室有限公司 蛋白质富集的微泡及其制备和使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ

Also Published As

Publication number Publication date
CA2219651A1 (en) 1996-11-14
ZA963754B (en) 1997-11-10
DE69629367D1 (de) 2003-09-11
JPH11504931A (ja) 1999-05-11
CZ354797A3 (cs) 1998-02-18
HUP9801140A2 (hu) 1999-01-28
KR19990014708A (ko) 1999-02-25
HK1016064A1 (en) 1999-10-29
CN1100539C (zh) 2003-02-05
ES2205042T3 (es) 2004-05-01
IL118219A (en) 2001-08-26
ATE246504T1 (de) 2003-08-15
WO1996035423A1 (en) 1996-11-14
NO975134D0 (no) 1997-11-07
CA2219651C (en) 2007-03-27
US5985906A (en) 1999-11-16
DK0824350T3 (da) 2003-11-03
MX9708699A (es) 1998-02-28
KR100443535B1 (ko) 2004-12-17
CZ291144B6 (cs) 2002-12-11
AU5818396A (en) 1996-11-29
EP0824350A1 (en) 1998-02-25
PL322749A1 (en) 1998-02-16
GB9509631D0 (en) 1995-07-05
EP0824350B1 (en) 2003-08-06
HU224920B1 (en) 2006-04-28
DE69629367T2 (de) 2004-06-09
CN1184427A (zh) 1998-06-10
PT824350E (pt) 2003-12-31
FI120079B (fi) 2009-06-30
IL118219A0 (en) 1996-09-12
AU712914B2 (en) 1999-11-18
FI973812A0 (fi) 1997-09-26
FI973812A (fi) 1997-11-11
NO317030B1 (no) 2004-07-26
NO975134L (no) 1997-11-07
SK150797A3 (en) 1998-05-06
HUP9801140A3 (en) 2000-07-28
TW464492B (en) 2001-11-21

Similar Documents

Publication Publication Date Title
CY2496B1 (en) Antifungal composition.
LU93229I2 (fr) "pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate"
DE69431194D1 (de) Amidino-derivate nützlich als no synthase-hemmer
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
NZ300942A (en) 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
IL116887A0 (en) Cationic copolymers of vinyl amine and vinyl alcohol for the delivery of oligonucleotides
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
IL152908A0 (en) USE OF (+)-a- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL) ETHYL] -4-PIPERIDINEMETHANOL OR ITS PRODRUG IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND DOPAMINE INDUCED PSYCHOSIS
NO981019D0 (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
WO2001004354A3 (en) Use of ras inhibitors of inhibiting muscle atrophy
EP0566666A4 (en) Novel glucohydrolase inhibitors useful as antidiabetic agents
NO975084L (no) Bakteriostatisk preparat og dets anvendelse i metallbearbeidingsfluider
GR3035459T3 (en) Steel, method for its manufacture, its use and product made from steel
MX9603305A (es) Proceso mejorado para la ruptura de emulsiones de aceite.
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
ITMI20000908A0 (it) Metodo e sistema per l'assicurazione di un investimento in titoli azionari e similari.
DK0891322T3 (da) Dimethylsubstituerede cyclohexandienderivater
UA42111C2 (uk) Засіб для прихованого маркування небіологічних об'єктів
PL322847A1 (en) Condensed b-carbolins
ITRM930688A1 (it) Alimentatore particolarmente adatto per linee di confezionamento di giornali, riviste e simili.